MedPath

Effectiveness of medicated nasal drops in headeche

Phase 1
Conditions
Health Condition 1: R51- Headache
Registration Number
CTRI/2019/07/020224
Lead Sponsor
PDEAs college of Ayurveda and Reasearch center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients showing classical lakshnas of Ardhavabhedak (Ardhashirshula, Bhrama, Prakashasahatva, Shiropatateev(Lightheadness), Hrullas) will be selected for the study.

2) Patients of age group above 25 yrs. and below 60 yrs.

3)Patients will be selected irrespective of gender ,age, religion, occupation, economic and educational status.

4)Willing and able to participate in the study

5)Clinical history of patients will be taken in special prepared case sheet Performa.

Exclusion Criteria

1.Known case of Ardhavabhedaka who is taking other treatment will be excluded.

2.Known case of Hypertension, COPD and other chronic disease.

3.Known case of secondary headaches like meningitis, brain tumor, encephalitis, cervical Spondylitis, refractive errors & glaucoma, Head injury

4.Known case of sinusitis will be excluded from study.

5. Nasya anarha people will be excluded from study.

6.Patients who are incapacitated, bedridden or confined to a wheelchair.

7.Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants, anticholinergics etc. or any other drugs that may have an influence on the outcome of the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of Goghritmand Nasya and Sharkarayukta Narikelajalanasya in the management of ArdhavabhedakaTimepoint: 30 days with follow up on 8th,15th, 22th, 29th day with window period of 5 days
Secondary Outcome Measures
NameTimeMethod
To observe any adverse events found if any during the study.Timepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath